These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6982737)

  • 1. Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.
    Ruggeri ZM; Lombardi R; Gatti L; Bader R; Valsecchi C; Zimmerman TS
    Blood; 1982 Dec; 60(6):1453-6. PubMed ID: 6982737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
    Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
    Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
    Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
    N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
    Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
    Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).
    Ruggeri ZM; Nilsson IM; Lombardi R; Holmberg L; Zimmerman TS
    J Clin Invest; 1982 Nov; 70(5):1124-7. PubMed ID: 6982283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay.
    Scott JP; Montgomery RR
    Am J Clin Pathol; 1991 Dec; 96(6):723-8. PubMed ID: 1746488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
    Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO
    Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma.
    Holmberg L; Berntorp E; Donnér M; Nilsson IM
    Blood; 1986 Sep; 68(3):668-72. PubMed ID: 3488775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to desmopressin in type IID von Willebrand's disease.
    Thomas N; O'Callaghan U; Lowe GD; Olszynski V; Kernoff PB; Abildgaard CF; Tuddenham EG
    Clin Lab Haematol; 1989; 11(3):189-97. PubMed ID: 2591151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
    Weiss HJ; Sussman II
    Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo interaction of von Willebrand factor with platelets following cryoprecipitate transfusion in platelet-type von Willebrand's disease.
    Miller JL; Boselli BD; Kupinski JM
    Blood; 1984 Jan; 63(1):226-30. PubMed ID: 6418233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment.
    Goudemand J; Samor B; Caron C; Jude B; Gosset D; Mazurier C
    Br J Haematol; 1988 Feb; 68(2):227-33. PubMed ID: 3126793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR; Williams SB; Shafer BC; Corash L
    Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of von Willebrand factor: relationship to von Willebrand's disease.
    Ruggeri ZM
    Mayo Clin Proc; 1991 Aug; 66(8):847-61. PubMed ID: 1907344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation and alpha granule secretion in type IIB von Willebrand's disease.
    Gralnick HR; Williams S; McKeown LP; Connaghan G; Shafer B; Hansmann K; Magruder L; Vail M
    Br J Haematol; 1991 Dec; 79(4):618-23. PubMed ID: 1722992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further characterization of platelet-type von Willebrand's disease in Japan.
    Takahashi H; Handa M; Watanabe K; Ando Y; Nagayama R; Hattori A; Shibata A; Federici AB; Ruggeri ZM; Zimmerman TS
    Blood; 1984 Dec; 64(6):1254-62. PubMed ID: 6333901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.